Lapatinib

• Post Date:

  Dec 02,2024

• Expiry Date:

  May 31,2025

• Detailed Description:

  Cas No. :231277-92-2 lapatinib;n-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-((2-methylsulfonylethylamino)methyl)-2-furyl)quinazolin-4-amine

• CAS Registry Number:

  231277-92-2

• Synonyms:

  ;4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-;N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine;N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine;N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine;Lapatinib base;

• Molecular Formula:

  C₂₉H₂₆ClFN₄O₄S

• Molecular Weight:

  581.0575

• Molecular Structure:

  

• Company:

  Nanjing CHICO pharmaceutical Co.,Ltd     [ China ]          

• Contact:

  Mr WU

• Tel:

  +86-25-84351604

• Fax:

  +86-25-52261140

• Email:

  sales@chicopharm.com